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1. Introduction 
Demographic evolution represents a challenge for public health. Global population, 
especially in the developed countries is aging. The proportion of the population above 60 
years has increased from 8% in 1950 to 10% in 2000 and is expected to reach 21% by 2050. 
Older people suffer from more frequent and more severe community-acquired and 
nosocomial infections than younger people. The clinical presentation is often atypical 
making diagnostic more difficult. “Latent” intracellular pathogens such as viruses 
(Herpesviridae) or Mycobacteriae are more prone to reactivate while opportunistic 
infections (such as Candida) manifest at increased rates (Ongradi & Kovesdi, 2010). Older 
individuals suffer from reactivation of mycobacterium tuberculosis that counts for 15 
percent of all geriatric pulmonary infections. There is also an age-related decline in the 
magnitude of the responses to vaccination. Low-level chronic inflammation, a process 
referred to as “inflamm-aging”, is commonly observed in older people. It results in both 
decreased immunity to exogenous antigens and increased autoreactivity. It is well 
documented that a significant fraction of older people are positive for low affinity 
autoantibodies without clinical significance. Rheumatoid factors are present in up to 5% of 
young healthy individuals, a proportion that increases up to five times in older persons.  
Similarly, the prevalence of antinuclear antibodies is higher in healthy individuals over 70 
years of age compared to healthy young adults (Grolleau-Julius et al., 2010). Furthermore, 
older persons are more susceptible to develop cancer, probably because of accumulation of 
cell damages and reduced “immunosurveillance”(Malaguarnera et al., 2010; Fulop et al., 
2010). 
There is clear evidence of an age-related decline in effectiveness of the immune system in 
humans; it is common to most if not all vertebrates and to some invertebrates. For example, 
drosophilae display pro-inflammatory status with increasing age and have reduced capacity 
to produce antimicrobial peptides in response to infection. There is also substantial body of 
evidence reporting immunosenescence in wild birds (decline of T- and B-cell functions and 
altered innate immune responses) and mice (thymic atrophy and reduced recent thymic 
emigrants) (Shanley et al., 2009). Immunosenescence is characterized by the deleterious 
“filling” of the immunological space with memory and effector cells as a consequence of 
exposure to a variety of antigens. The continuous attrition caused by clinical and subclinical 
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infections as well as the continuous exposure to other types of antigens (food, allergens) is 
likely to be responsible for the chronic activation of the immune system and inflammation. 
Immunosenescence process along with morbidity and mortality will be accelerated in those 
subjects who are exposed to an extra-burden of antigenic load. The phenomenology of HIV+ 
patients after several years of infection shows striking similarities (regarding T cell subset 
rearrangement, T cell clonal expansion, and telomere shortening) with that observed in the 
context of aging. It is tempting to speculate that chronic infections with other micro-
organisms could also lead to this process (De Martinis et al., 2005). 
Many studies have tried to collect immune data in older people to establish reliable 
“biomarkers of aging”. However, the literature is full of confusing and conflicting data. There 
are many difficulties in interpreting immunogerontological observations. The major concern is 
the way “young” and “old” populations are defined in these studies. On one hand, restricting 
selection to only “healthy” older people might introduce a bias and not be representative of 
the general population. On the other hand, comorbidities that are encountered in the geriatric 
population will certainly affect many parameters of the immune responses. Some studies try to 
restrict inclusion criteria to better characterize age-associated alterations of immunity such as 
the SENIEUR protocol (Wikby, 2008; Chen et al., 2009; Ligthart et al., 1984). Unfortunately, it 
does not represent our geriatric population (only 10% of older people meet the criteria) (Chen 
et al., 2009). OCTO study was less restrictive for inclusion criteria, admitted 400 octogenarians 
that were not institutionalized, had no or only mild cognitive dysfunction and were not on 
drug regimen that might have influenced the immune system. This study predicts the same 
immune risk profile (IRP) of subsequent 2 year-mortality than SENIEUR protocols 
characterized by high level of CD8 T cells, inversion of the CD4+/CD8+ T cell ratio, poor 
mitogen stimulated lymphoproliferative responses and loss of CD28 costimulatory molecule 
(table 1).  
Immune Risk Phenotype (IRP)
- Low levels of B cells
- Inversion of the CD4+/CD8+ ratio
- Poor mitogen stimulated lymphoproliferativeresponse
- Increased levels of CD8+ CD28- CD57+ T cells
- Positive serology for Cytomegalovirus
 
Table 1. The “immune risk phenotype”. 
Finally, the NONA study did not exclude individuals because of compromised health to place 
immune risk phenotype in a broader context of health and cognitive dysfunctioning. It 
confirmed the OCTO study and demonstrated that the immune risk phenotype concept could 
be generalized to a sample of nonagenarians not specifically selected for good health at 
baseline (Pawelec et al., 2005; Wikby, 2008). Both studies demonstrated that aging is associated 
with low-grade inflammation and that inflammatory markers like increase of IL-6, C-reactive 
protein (CRP) and decrease of albumin are significant predictors of mortality in very old 
humans independently of disease and comorbidity (Wikby, 2008). The new HEXA study 
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examined the IRP profile in hexagenarians and shows the same characteristics than in the very 
old. The study has now to examine the impact of the IRP on morbidity and mortality in this 
age group (Wills et al., 2011). 
Herein, we will first review the major changes in adaptive immune responses observed in 
the geriatric population. We will then focus on what is known about innate immune 
responses in this age group. Finally, we will discuss the links between the specific clinical 
context of aging and alterations of immune responses.  
2. Adaptative immune responses: thymic involution, T cell exhaustion and 
persistent infections 
2.1 Thymic involution  
The thymus is the site of T cells differentiation and maturation and is often referred to as the 
“immunologic clock” of aging. Age-associated thymic involution is a well-recognized factor 
associated with immunosenescence, and in particular with reduced vaccine efficacy. The 
thymus undergoes a progressive involution and the output of new cells falls significantly. 
Thymic functions already start decreasing after one year of life but the process becomes 
significant after 40 years of age. The expansion of perivascular space (adipocytes, peripheral 
lymphocytes, stroma) with age is such that thymic epithelial space represents less than 10% 
of the total thymic tissue by 70 years of age. When extrapolated, data suggest that the 
thymus would cease to produce new T cells by 105 years of age (Boren & Gershwin, 2004; 
Ongradi & Kovesdi, 2010; Gruver et al., 2007). There might be a benefit for the organism to 
reduce cell proliferation within the thymus, once a T-cell repertoire is established, so that 
energy can be devoted to other physiological processes (Shanley et al., 2009). Both intrinsic 
and extrinsic factors are thought to be involved in this process (Boren & Gershwin, 2004). 
Thymic epithelial cells produce a number of factors that can be thymosuppressive 
(Interleukin (IL)-6, LIF, OSM) or thymostimulatory (interleukin (IL)-7, Keratinocyte growth 
factor, Thymic stromal lymphopoïetin, growth hormone, leptin). Thymic atrophy is 
mediated by upregulation of thymosuppressive and decrease of thymostimulatory 
cytokines such as IL-7. This cytokine plays an important role for thymus function 
maintenance; it promotes thymopoiesis by maintaining anti-apoptotic protein Bcl-2 and 
inducing V-DJ recombination (Ongradi & Kovesdi, 2010; Gruver et al., 2007). Extrathymic 
factors including zinc, thymulin, cathepsin L, melatonin, thyroid hormone, growth hormone 
also contribute to thymus function. Stressful events, such as infections, septic shock, 
malnutrition, pregnancy, chemotherapy or irradiation have been associated with reversible 
thymic involution. Exogenous administration of leptin prevents this stress-induced thymic 
involution in mice, suggesting possible therapeutic intervention in aged humans 
(McElhaney & Effros, 2009; Boren & Gershwin, 2004; Gruver et al., 2007; Gruver et al., 2009; 
Hick et al., 2006). However, it is unclear whether age-associated and stress-induced thymic 
involutions result from the same mechanisms (McElhaney & Effros, 2009; Boren & 
Gershwin, 2004; Gruver et al., 2007). “Thymic rejuvenation” techniques have been sought 
for many years. Keratinocyte growth factor, IL-7 and ghrelin are interesting candidates 
(McElhaney & Effros, 2009; Aspinall et al., 2007). Keratinocyte growth factor enhances IL-7 
production in the thymus, promoting development and maintenance of T cells following 
vaccination. IL-7 treatment has been shown to increase thymic output and number of central 
memory T cells and improve the antibody response to influenza vaccination in aged rhesus 
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macaques (McElhaney & Effros, 2009). Intrathymic infection with IL-10-expressing 
adenovirus can prevent thymocyte apoptosis induced by sepsis in mice (Ongradi & 
Kovesdi, 2010; Gruver et al., 2007).  
Thymic involution causes a continuous drop in the output of recent thymic emigrants while 
homeostatic mechanisms attempt to maintain constant peripheral T cell numbers. Consistent 
with greater proliferative history, naïve T cells from elderly have less T cell receptor excision 
circle (TREC) numbers and shorter telomere length (see below) (Ferrando-Martinez et al., 
2011). However, the total number of T cells shows very little decline with advancing age, 
except in the very old. Furthermore, the proportion of naïve and memory T cells is well 
maintained up to the age of 65 years. It has been postulated that the majority of naïve T cells 
in the adult are generated by cell division of existing T cells, rather than thymic export. The 
repertoire of naïve CD4 T cells is also very well maintained up to the age of 65 years. It then 
dramatically dwindles and is found to be severely contracted and undistinguishable from 
the repertoire of memory T cells at 75-80 years of age. The same phenomenon is shown for 
naïve CD8 T cells. IL-7 plays an essential role in controlling homeostatic proliferation of 
naïve CD4+ and CD8+ T cells (Ferrando-Martinez et al., 2011; Arnold et al., 2011; Naylor et 
al., 2005; Kilpatrick et al., 2008). 
 
Table 2. Main lymphocyte subsets. 
2.2 T lymphocytes 
Memory and naïve human T cells are distinguished by their expression of members of the 
CD45 family surface antigens. CD45RA antigen is expressed primarily on naïve T 
lymphocytes and CD45RO is present on the cell surface of memory T lymphocytes (Figure 
1). With normal aging, the slow turnover and long lifespan of naïve T cells are preserved but 
thymus output diminishes gradually and ultimately becomes insufficient to replace naïve T 
cells lost from the periphery. Conversely, cumulative chronic exposure to pathogens and 
environmental antigens promotes the accumulation of memory cells and eventually a state 
of “exhaustion”. This phenomenon is associated with increased complication risk following 
viral illnesses such as influenza, respiratory syncytial virus and reactivation of herpes 
viruses (McElhaney & Effros, 2009; Desai et al., 2010). 
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In aged mice, formation of “immunological synapse” between CD4 T cells antigen 
presenting cells is hindered. This has been related to altered cholesterol/phospholipid ratio 
in lymphocyte membranes, leading to impaired T cell receptor (TCR)-dependent 
recruitment of signal molecules to the immunological synapse. In humans, alteration in the 
cholesterol/phospholipid ratio of lymphocyte membranes has also been documented and is 
associated with reduced proliferation rate (Arnold et al., 2011; Huber et al., 1991; Stulnig et 
al., 1995). With age, human and murine T cells tend to secrete less IL-2, an observation 
linked to important alterations in the proximal TCR signalling pathway (Boren & Gershwin, 
2004; Fulop et al., 2007; Chakravarti & Abraham, 1999). Peripheral blood lymphocytes from 
aged individuals also display decreased NFAT expression, a key transcription factor 
implicated in IL-2 gene activation (Rink et al., 1998; Mysliwska et al., 1998; Wikby et al., 
1994; Desai et al., 2010; DiPenta et al., 2007). However, when only “healthy older” people are 
considered (SENIEUR protocol), production of IL-2 was not different from that observed in 
younger individuals (Chen et al., 2009). 
 
CD8+ T cells
CD4+ T cells
Naive T cells:
CD45RA+
CCR7+
CD28+
CD27+
Naive T cells:
CD45RA+
CCR7+
CD28+
CD27+
Central Memory T cells:
CD45RA-
CCR7+
CD28+
CD27+
Central Memory T cells:
CD45RA-
CCR7+
CD28+
CD27+
Effector Memory T cells:
CD45RA-
CCR7-
CD28-
CD27+
Effector Memory T cells:
CD45RA-
CCR7-
CD28+
CD27-
Effector Memory RA+ T cells:
CD45RA+
CCR7-
CD28-
CD27-
Effector Memory RA+ T cells:
CD45RA+
CCR7-
CD28-
CD27-
 
Fig. 1. Phenotype of different lymphocytes T cells subsets. 
CD4 T lymphocytes from aged mice display decreased CD40L expression. In humans, 
CD40L expression is also reduced on peripheral blood CD4 T cells upon anti-CD3 
stimulation in old people compared to younger individuals (Fernandez-Gutierrez et al., 
1999). As this molecule is critical for B-T cell interactions, it could participate to the 
alteration of humoral responses observed in the old population. The function of “follicular 
helper T cells” in older people should be revisited in the light of the recent advances in the 
field (Ongradi & Kovesdi, 2010; Gruver et al., 2007; Crotty, 2011).  
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2.2.1 Naïve T cells 
Naïve T cells from young and old adults differ significantly. Compared to young adults, 
40% of human naïve CD8+ CD28+ T cells of older people do not express CD62L and CCR7, 
two receptors implicated in the migration to peripheral lymphoid tissues (Ongradi & 
Kovesdi, 2010; Aspinall et al., 2007). In humans, naïve CD8 T cells seem to be more 
susceptible to death receptor-mediated apoptosis and are more affected by age-related 
changes than the CD4+ T cell pool (Gupta & Gollapudi, 2006; Gupta & Gollapudi, 2008). 
CD45RA+CD28+CD8+ T cells from older people produce larger amounts of interferon 
(IFN) upon polyclonal stimulation than those from young persons (Pfister & Savino, 
2008). 
As mentioned earlier, IL-7 plays an essential role in controlling homeostatic proliferation of 
naïve CD4+ and CD8+ T cells and supports the survival of naïve CD8+ T cells. IL-7 acts in 
conjunction with T cell receptor signals from contact with self-MHC/peptide that sustain 
the expression of anti-apoptotic molecules. However, this extended lifespan of naïve T cells 
could be associated with prolonged exposure to unfavourable environmental factors which 
cause DNA damage and contribute to decreased function in old age (Arnold et al., 2011). 
2.2.2 Memory T cells  
The three protocols (SENIEUR, OCTO and NONA) compared immune risk phenotype in 
older people with different state of comorbidities. Aging is associated with an increase of 
memory cells, a decrease of naïve T cells and a loss of CD28 molecules. Chronic 
cytomegalovirus (CMV) infection has been proposed as the main stimulus driving the in 
vivo process of “replicative senescence” (see section 4.3). CMV is associated with clonal 
expansion of CD8 T cells, increased numbers of CD8+ CD28- T cells, largely terminally 
differentiated effector memory T cells expressing CD45RA CCR7- (effector memory T cells, 
“EMRA”) and inverted CD4:CD8 ratio (McElhaney & Effros, 2009; Pawelec & 
Derhovanessian, 2011; Pawelec et al., 2005; Derhovanessian et al., 2010). This will be further 
developed in this chapter. 
 Much effort has been dedicated to characterize cellular markers of immunosenescence. 
While T cell receptor repertoire contraction is a characteristic of the aging immune system, 
there is increasing evidence that clonal T cells of older persons may express a variety of 
receptors normally found on natural killer (NK) cells such as CD16, CD56, CD57, CD94, 
CD161, NKG2D and KIR family. NK receptors expression can have profound impact on 
immunity. Whereas, NK receptors diversity defines functional subsets of NK cells that 
contribute to normal innate antigen-independent responses, it is proposed that NK receptors 
expression on T cells from aged individuals is an adaptive mechanism of immunological 
diversity in the midst of a contracting T cell receptor repertoire. Studies with in vitro 
replicative senescence systems indicate stable NK receptors expression on T cells follows the 
loss of CD28 (Abedin et al., 2005; Alonso-Arias et al., 2011; Rajasekaran et al., 2010). 
Expression of CD57 is also found on T lymphocytes, where it is currently considered as a 
marker for “replicative senescence” (also termed “clonal exhaustion”) i.e., a high 
susceptibility to activation-induced cell death and the inability to undergo new cell-division 
cycles despite preserved ability to secrete cytokines upon encounter with their cognate 
antigen. The phenotypes associated with replicative senescent CD8+ T lymphocytes are not 
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well defined but are generally attributed to lack of CD28 or expression of CD57. 
CD8+CD57+ T lymphocytes have high cytotoxic effector potential including perforin, 
granzymes and granulysin. At the messenger and protein levels, CD8+CD57+T 
lymphocytes express more adhesion molecules and fewer chemokine receptors (CCR7 and 
CXCR4) than CD8+CD57– T lymphocytes but preferentially express CX3CR1. The lower 
expression level of genes involved in cell-cycle regulation supports the limited proliferation 
capacities of CD8+CD57+ T lymphocytes, even in response to polyclonal or cytokine 
stimulation (Focosi et al., 2010). 
As detailed below, these CD8+CD57+T lymphocytes are commonly found in individuals 
with chronic immune activation and increase in frequency with age (from absence in 
newborns to 15–20% of circulating CD8 T cells), but the percentage of CD8+CD57+ cells 
increases in a series of clinical conditions whose common denominator is functional 
immune alteration, including HIV and CMV infections, common variable 
immunodeficiency, hematological cancers and autoimmune diseases (Pawelec & 
Derhovanessian, 2011; Focosi et al., 2010). OCTO, NONA and SENIEUR protocols conclude 
that the number of cells in the CD57+CD28-, CD45RACD27- and CD57+CD56+CD8+ T cells 
subsets in older people were independent of the individual’s health status (disease 
interfering with immunity were excluded) (Nilsson et al., 2003). In older humans, CD4 T 
cells also express more NKG2D molecules and are associated with replicative senescence. 
NKG2D+ CD4+ T cells are mostly CD28- CD4+ T cells and also present cytotoxic properties 
(Alonso-Arias et al., 2011). These senescent cells resulting from permanent immune 
activation are potent producers of proinflammatory cytokines and have shorter telomeres 
than NKG2D- CD4+ T cells (Ongradi & Kovesdi, 2010; Gruver et al., 2007). Immune 
phenotype of T cells is correlated with individual “fitness” in individuals over 78 years. 
Unimpaired aged individuals display T cells expressing inhibitory NK receptors (CD158a, 
CD158e and NKG2a) and functionally impaired aged individuals display T cells expressing 
stimulatory NK receptors (CD56, CD16, NKG2D) (Vallejo et al., 2011). 
It has been shown that high proportions of CD8+ CD25+ memory T cells are associated with 
healthy aging and are rare or absent in older people with latent CMV infection. The 
presence of CD8+CD25+ T cells is associated with the maintenance of intact humoral 
responses. They produce IL-2 and IL-4, assist B memory generation, induce MHC II 
upregulation on B cells, and promote antibody isotype switching to IgG1 and IgE. These T 
cells coexpress CD4 molecule and present a highly diverse TCR repertoire and longer 
telomere compared to the CD8+ CD25- subset (Herndler-Brandstetter et al., 2005). 
Aged individuals (more than 65 years) have an increase in peripheral blood regulatory T 
cells expression. The increase of this population seems to be linked to the healthy state of 
elderly people. The in vitro function of this population is not altered with age (Ongradi & 
Kovesdi, 2010; Gruver et al., 2007; Gregg et al., 2005). 
T cells represent a minor population of human peripheral lymphocytes (1-10%). They play 
a role in antiviral and antitumoral immunosurveillance. They produce high levels of 
cytokines, mainly TNF and IFN. With increasing age, the absolute number of T cells and 
their proliferation rate is reduced while they express more TNF. Inversely, they present no 
change in IFN expression and cytolytic activity with age (Argentati et al., 2002). 
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2.3 B lymphocytes and humoral responses 
B cells also present alterations with increasing age. Decreased IL-7 production provokes a 
reduced ability to support B cell expansion by bone marrow stromal cells (Ongradi & 
Kovesdi, 2010). Bone marrow contains pluripotent stem cells that mature into bone tissue 
and cells that form peripheral blood cells, which further develop in specialized secondary 
compartments into functional immune cells. The stroma matrix of the bone marrow 
compartment is composed of accessory cells such as megakaryocytes, osteoblasts, 
osteoclasts, adipocytes, chondrocytes, myoblasts and fibroblasts. The hematopoietic 
compartment decreases with increasing age and is replaced by adipose tissue. Surprisingly, 
increased number of bone marrow resident macrophages is observed with age but these 
cells have decreased ability to secrete TNF. Both TNF and IL-1 are essential to promote 
secretion of other cytokines critical to stromal integrity, such as IL-6, IL-11, M-CSF or GM-
CSF. There is no clear evidence that hematopoietic cells number (CD34+) decreases with 
age. Hematopoietic cells give rise into common lymphoid progenitors like pro-B cells. There 
are discrepancies about the evolution of pro-B cells with age.  Conversely, pre-B cells 
decrease markedly with age (Gruver et al., 2007). 
The proportion and numbers of total B cells (CD19+) decrease with age. Data on specific B 
cell subsets is less clear. Naïve B cells are defined as IgG- IgA- IgD+ CD27- whereas memory 
B cell population is very heterogeneous, comprising three subtypes (Figure2): “IgM 
memory” cells (that are IgD+ IgM+ CD27+, important against bacterial infections), “classical 
switched memory” (IgG+/IgA+ CD27+) and “double negative” B cells (IgG+/IgA+, IgD- 
CD27- B cells). This later group could emerge independently from T cell help.  
Naive B cells:
CD19+
CD10-
CD21++
CD20+
IgG-
IgA-
IgM-
IgD+
CD27+
B lymphocytes:
Unswitched or IgM+ 
memory B cells:
CD19+
CD10-
CD20+
CD21+
IgG-
IgA-
IgM+ 
IgD+
CD27+
Classical or switched 
memory B cells:
CD19+
CD10-
CD20+
CD21+
IgG+
IgA+
IgM-
IgD-
CD27+
Atypical or double negative 
memory B cells:
CD19+
CD10-
CD21low
CD20+
IgG+
IgA+
IgD-
CD27-
Plasma cells:
CD19+
CD20-
CD21-
IgG+/-
IgA+/-
IgM-
CD27+
 
Fig. 2. Phenotype of different B lymphocyte cells subsets. 
Proportion of naïve B cells decreases with age. Several reports indicate that the proportion 
and number of CD27+ (memory) B cells increase but other reports show the opposite (Bulati 
et al., 2011; Colonna-Romano et al., 2009). The discrepancy probably reflects differences in 
the subsets definition and study protocols. Naïve B cells exhibit a reduced susceptibility to 
apoptosis in aged individuals (Chong et al., 2005). B cells produce large amounts of 
proinflammatory cytokines upon CD40 and IL-4 activation and so could play a role in the 
generation or in the maintenance of the inflammatory environment of the older people 
(Buffa et al., 2011). The “IgM memory” subset decreases with age. Other reports indicate a 
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decrease of “switched memory” B cells. Finally the proportion of “double negative” B cells 
seems to increase with age (Ademokun et al., 2010; Bulati et al., 2011; Colonna-Romano et 
al., 2003; Colonna-Romano et al., 2009; Chong et al., 2005). This “double negative” 
population in aged individuals presents reduced expression of CD40, HLA-DR and CD80 
and shorter telomeres. These cells are also present in patients with systemic lupus 
erythematosus (Colonna-Romano et al., 2009). There is a significant increase of anergic, 
“exhausted” memory cells with CD27 downregulation (CD27-) in older people. In 
centenarians, naïve B cells (IgD+ CD27-) are more abundant whereas exhausted memory 
cells (IgD- CD27-) do not show the increase previously demonstrated in healthy older 
people. Authors conclude that the reservoir of naïve B cells might be one factor of 
“successfully aging” (Ongradi & Kovesdi, 2010; Fernandez-Gutierrez et al., 1999). 
B cells progenitors undergo maturation and differentiation in secondary lymphoid tissue, 
such as spleen and lymph nodes. Spleen arteries are surrounded by T lymphocytes in the 
periarteriolar lymphoid sheath. Primary lymphoid follicules containing B cells are adjacent 
to the periarteriolar lymphoid sheath. Other cell types such as T cells, dendritic cells and 
macrophages make up the marginal zone. This constitutes the white pulp. Age-associated 
architectural changes have been documented.  Spleen from aged humans demonstrates a 
decrease in arterial vessels and an increase in stromal cells over lymphocytes. Total splenic 
weight increases with age due to fibroblastic infiltration (Gruver et al., 2007).  
The germinal centre reaction is essential for the generation of high affinity antibody in 
response to infectious agents.  This process is accomplished by two distinct mechanisms: 
class switch recombination, which enables B cells to change antibody isotype, and somatic 
hypermutation, the process of introducing mutations into the B cell receptor to increase 
antigen affinity. Data indicate that there is no change in the fundamental mechanisms of 
somatic hypermutation with age in man but an impaired ability of class switch 
recombination has been described in aged mice (Ademokun et al., 2010).   
There is also a collapse in B cell receptor repertoire diversity with age and an expansion of 
monoclonal cells. The incidence of “monoclonal gammopathy of undefined significance” 
(MGUS) has been shown to increase with age. Sensitive assays reveal that as many as 50% of 
old mice and 20% of elderly humans have serum monoclonal immunoglobulin. As half of 
serum monoclonal immunoglobulins reacts with autoantigens, it appears that cells 
producing monoclonal immunoglobulins are drawn preferentially from the population of 
“B1 cells” that expand with age in both humans and mice (Weksler & Szabo, 2000). These 
CD5+CD20+ cells are produced during fetal live and are T-independent (in contrast to CD5- 
CD20+ “B2 cells” that are produced post-natally and are T-dependent). In humans, 
approximately 1% of old subjects with serum monoclonal immunoglobulin develop 
multiple myeloma each year, derived probably from plasma cell clonal expansions. Chronic 
lymphocytic leukemia, another lymphoid malignancy that occurs late in life, may arise from 
malignant transformation of the large B-cell clonal expansions. Chronic lymphocytic 
leukemia is frequently associated with T-cell abnormalities, including an inversion of the 
normal CD4 to CD8 T cell ratio, expansions of large granular lymphocytes, and clonal 
expansions of CD4 and CD8 T cells. These T-cell clonal expansions may represent a 
clonotypic response to transformed B cells or their secreted immunoglobulins. This 
hypothesis is supported by the finding that T cells from myeloma patients can be activated 
by monoclonal Ig fragments (Ademokun et al., 2010; Bulati et al., 2011; Colonna-Romano et 
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al., 2003; Weksler & Szabo, 2000). However, in humans, despite the reduced number of B 
cells and the defects in class-switching, serum IgG, IgA are increased with age; IgD levels 
decrease with age but IgE and IgM remain unchanged or are decreased. IgG1 and IgG3 (in 
men) subtypes are also increased with age (Ademokun et al., 2010; Bulati et al., 2011; 
Colonna-Romano et al., 2003). 
The quality of the humoral response also declines with age, characterized by lower antibody 
responses and decreased production of high affinity antibodies. B cells from aged 
individuals can be directly activated by cytokine but are weakly activated by anti-CD3 
activated PBMCs. This result suggests that poor B cell responses is a consequence of 
inadequate help from T cells (Ongradi & Kovesdi, 2010; Fernandez-Gutierrez et al., 1999). In 
mice, aged CD4+ T cells provide poor assistance in germinal centres and promote low-
affinity antibody production. Furthermore, overproduction of Th2 cytokines could augment 
B cell-mediated autoimmune disorders by enhancing the production of autoreactive 
antibodies. The percentage of naïve follicular B cells declines whereas subsets of antigen-
experienced mature B cells with longer life span increase including poly/self reactive 
subtypes. These cells may be reactivated due to age-associated reduced tolerance or loss of 
tissue integrity leading to the exposure of neo-self antigens that results in aberrant 
autoimmune response (Ongradi & Kovesdi, 2010). Taken together, these data indicate that 
in older people, B cell repertoire diversity is limited while there is an increase of polyspecific 
and auto-antibodies. 
3. Innate immune responses and aging.  
3.1 Monocytes and dendritic cells subsets, neutrophils 
Monocytes represent about 5-10% of peripheral blood leukocytes in humans. They originate 
from a myeloid precursor in the bone marrow, circulate in the blood and spleen then enter 
tissues. Monocytes represent circulating precursors for tissue macrophages and dendritic 
cells. The differential expression of CD14 (part of the receptor for LPS) and CD16 (also 
known as FcRIII) are commonly used to define two major subsets (Figure 3): “classical” 
CD14++ CD16- cells, representing 95% of monocytes in healthy individuals and the “non-
classical” CD14+ CD16+ comprising the remaining fraction. This later population is 
considered to represent activated cells that have undergone CD16 upregulation and CD14 
downregulation and have been implicated in the pathogenesis of atherosclerosis. In healthy 
older volunteers, there is a shift of “classical” to “non-classical” monocytes. While 
“classical” monocytes express CCR2, “non-classical” monocytes preferentially express 
CX3CR1. Expression intensity of CXCR3 tends to decrease with age (Seidler et al., 2010; 
Sadeghi et al., 1999). 
Dendritic cells (DCs) play a key role in the immune system since they orchestrate initiation, 
amplification and suppression of immune responses.  In particular, maturation of DCs is 
crucial for the initiation of immunity.  In fact, immature DCs are extremely efficient in 
capturing and processing antigens, but their unique ability to potently activate naïve T 
lymphocytes is acquired after maturation. This process is accompanied by the up-regulation 
of major histocompatibility complex molecules and the increased expression of membrane 
molecules that interact with T lymphocytes to enhance cell activation and adhesion. 
Furthermore, DC maturation leads to the release of high levels of cytokines that are  
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Main subsets of blood innate immune cells
Granulocytes :
Neutrophils
Eosinophils
Basophils
Monocytes :
« Classical » monocytes : 
CD16- CD14++
Inflammatory monocytes :  
CD16++ CD14+
CD16++ CD14-
Dendritic cells :
Plasmacytoid DC
CD123+ CD11c-
Myeloid DC
CD123- CD11c+
 
Table 3. Blood innate immune cells. 
 
 
Fig. 3. Major subsets of monocytes. 
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responsible for the regulation and polarization of both innate and acquired immune 
responses (Ciaramella et al., 2011; Agrawal et al., 2007a). DCs are heterogeneous and are 
subdivided into two major categories: those that are present in peripheral blood (myeloid 
and plasmacytoid DCs) and those that are present in tissue/organs (Langerhans cells, 
interstitial and interdigitating DCs) (Agrawal et al., 2007b). Myeloid DCs express CD11c+ 
and low level of CD123 and can be subdivided into CD16+ (40-80%), CD1b/c+ (20-50%) and 
BDCA3+ (2-3%) subpopulations (Figure 4). Plasmacytoid DCs express low level of CD11c, 
high level of CD123, BDCA2 and BDCA4 and are specialized for production of type I IFNs 
in the context of viral infections (MacDonald et al., 2002; Dzionek et al., 2000).   
Dendritic cells:
Plasmacytoid DC :
TLR7/TLR9
CD123+
BDCA2+
BDCA4+
Myeloid DC :
TLR1 to 8
CD11c+
BDCA1+
TLR1 to 8
CD11c+
CD16+
IFN┙
IFN┚
TLR1 to 8
CD11c+
BDCA3+
IL12
TNF┙
IL-6
IL-1
IL-10
 
Fig. 4. Major subsets of dendritic cells. 
In vitro monocyte-derived DCs, cultured with GM-CSF+IL-4, are closely related to 
interstitial or myeloid DCs (Agrawal et al., 2007b). Several studies used these in vitro 
cultured cells to assess the phenotype and functions of DCs in aged populations. Monocyte-
derived DCs present no clear differences of costimulatory or activatory molecules (HLA-DR, 
CD80, CD86, CD40, CD83) except for CD25 and ICAM after lipopolysaccharide stimulation 
in healthy older individuals compared to younger (Agrawal et al., 2007b; Ciaramella et al., 
2011; Agrawal et al., 2007a). Monocyte-derived DCs of older people are less efficient for 
micropinocytosis and phagocytosis of apoptotic cells and are impaired for migration 
(Agrawal et al., 2007b). 
Several reports indicate that there are no significant differences in numbers of circulating 
myeloid and plasmacytoid DCs between older people and young subjects and that the 
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expression of costimulatory molecules (CD86 and HLA DR) is similar (Agrawal et al., 2007a; 
Agrawal et al., 2007b; Pietschmann et al., 2000). In contrast, another study showed that 
numbers of myeloid DCs progressively declined with age while proportion of plasmacytoid 
DCs was unaffected. Peripheral blood DCs from healthy old subjects expressed CD86 and 
CD83, two markers of activation, on a higher percentage of cells, in comparison to young 
subjects. Maturation with lipopolysaccharide was unaffected with age (Della et al., 2007). 
Other studies showed reduced numbers of plasmacytoid DCs but not of myeloid DCs in 
healthy aged blood donors. Absolute numbers of circulating myeloid DCs is affected by 
declining health status (Perez-Cabezas et al., 2007; Panda et al., 2010; Shodell & Siegal, 2002; 
Jing et al., 2009). The use of Ficoll-enriched cells versus whole blood, differences in sample 
sizes, age groups, health status, genetic factors and subset definitions may contribute to the 
inconsistent findings with age in these studies. Taken together these data suggest that many 
factors, in addition to age itself, probably influence absolute/relative numbers or activation 
status of circulating DCs in geriatric populations.  
Neutrophils are key players for early responses to bacterial infections. They rapidly produce 
reactive oxygen and nitrogen species when pathogens are encountered and produce many 
pro-inflammatory mediators. Several studies have shown alterations of neutrophil functions 
with age. Data remain conflicting in the literature concerning their number and phagocytic 
functions. One suggested alteration is their propensity to undergo apoptosis because of 
augmented cell oxidative load and perturbation of anti-apoptotic/proapoptotic mechanisms 
(Tortorella et al., 2006). Several reports indicate reduced chemotaxis (Fulop et al., 2004), 
phagocytosis and production of superoxide anion. Negative feedback mechanisms could 
also be perturbated (Fulop et al., 2004; Wessels et al., 2010). In contrast, centenarians do not 
present neutrophil defects compare to old people for adherence, chemotaxis, superanion 
production (Wessels et al., 2010; Alonso-Fernandez et al., 2008); (Crighton & Puppione, 
2006). 
3.2 Toll-like receptors 
Toll-like receptors (TLR) are expressed on a variety of cells including macrophages, 
monocytes, natural killer cells, DCs, B and T lymphocytes.  To date, 10 TLR are functional in 
humans. Pathogen associated molecular patterns serving as TLR ligands include 
lipopolysaccharide (LPS) on gram (-) bacteria (TLR4), diacetylated (TLR2/6) and 
triacetylated (TLR1/2) lipopeptides, peptidoglycan (TLR2), bacterial flagellin (TLR5), 
nucleic acid and double-stranded RNA (TLR3), single stranded RNA (TLR7 and TLR8) and 
unmethylated CpG oligodeoxynucleotides (TLR9). Recognition of microbial components by 
TLR initiates MYD88 and TRIF-dependent signal transduction pathways that culminate in 
both the elaboration of proinflammatory cytokine responses (via NFB-dependent 
pathways) and the upregulation of type I IFNs and IFN-dependent genes. TLR-dependent 
activation of antigen presenting cells is a crucial step not only for the innate response but 
also for the ensuing initiation of the adaptive immune response. Inherited defects in TLR 
signaling are associated with a greater susceptibility to bacterial (especially Streptococcus 
pneumonia) and mycobacterial infection (Figure 5). Furthermore, TLR ligands as 
immunogens or adjuvants play an important role in mediating immune response to several 
human vaccines (Shaw et al., 2011; van Duin & Shaw, 2007).  
Several studies in humans and mice have shown that TLR expression and functions tend to 
decline with age (van Duin & Shaw, 2007). Human monocytes from aged individuals 
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present lower surface TLR1 expression than their younger counterparts (van Duin et al., 
2007). These studies revealed an age-associated reduction in TNF and IL-6 after 
stimulation of the TLR1/2 heterodimer. Similar observations were also noted for TLR7-
induced IL-6 production. There is a significant decrease in TLR-induced upregulation of 
CD80 in older compared to young for all TLR ligands (van Duin & Shaw, 2007; Shaw et al., 
2011). Myeloid DCs show decreased expression of TLR1, TLR3 and plasmacytoid DCs a 
decrease of TLR7 and TLR9 in older people compared to young individuals (Panda et al., 
2010; Jing et al., 2009). DCs from older donors had diminished late phase responses such as 
the induction of transcription factors STAT1 and IRF7 and lower expression of IRF1,  
TLR4
TLR1/2
TLR2/6
TLR5
MyD88 TRIF
MyD88
IRF5
IRF7
IRF3
NFkB
Type I interferon
Type I interferon
Proinflammatory 
cytokines
TLR7
TLR9
TLR3
Cellular membrane
endosome
endosome
 
Fig. 5. Toll like receptor signaling. 
suggesting a defective positive feedback regulation of type I IFN expression. Responses to 
TLR ligands may also be influenced by single nucleotide polymorphism within TLR genes. 
Authors report decreased IFN, IL-6, IL-8 and TNF in influenza virus-stimulated or HSV-
2-stimulated plasmacytoid DCs from older compared to younger individuals (Shaw et al., 
2011; Jing et al., 2009). IFN production may be restored by zinc supplementation (Rink et 
al., 1998). Stimulated myeloid DCs and plasmacytoid DCs with different TLR ligands show 
a reduced expression of TNF, IL-6, IL-12p40 and IFN in healthy older people but an 
increased of the basal levels of this cytokine in older people (Panda et al., 2010). This 
decrease in TLR-induced cytokine production was strongly associated with the inability to 
mount protective antibody responses to the trivalent inactivated influenza vaccine currently 
recommended (Panda et al., 2010). LPS-stimulated monocytes from old people were 
reported to express less IL-12/23p40 levels in comparison to monocytes from young 
individuals (Della et al., 2007). However, their capacity to produce either bioactive IL-12 or 
IL-23 has not been addressed.  
In contrast, analysis of monocyte-derived DCs from aged individuals revealed higher 
production of TNF, IL-6 and IL-18 in response to LPS- and ssRNA but no difference in IL-
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12p40/p70 (Ciaramella et al., 2011). There was no reduction of TLR4 expression with age but 
it was associated with decreased of phosphor-inositol 3(PI3) kinase, a negative regulator of 
TLR signalling. It manifested by decreased AKT phosphorylation and increased p38 
mitogen activated protein kinase activation. They also present an increased expression of 
phosphatase and tensin homolog (PTEN), a negative regulator of PI3 kinase signalling 
pathway (Shaw et al., 2011; Agrawal et al., 2007a; Agrawal et al., 2007b).  
Aging is generally associated with increased basal production of inflammatory cytokines 
but results of studies are often contradictory, depending on study designs and age groups 
(Beharka et al., 2001). Most studies report augmented plasma/serum levels of IL-6 and 
TNF with increasing age, even in “selected” SENIEUR elderly over 85 years of age (Krabbe 
et al., 2004; Della et al., 2007). An elevated circulating IL-6 level is a strong predictor of 
thromboembolic complications while elevated TNF levels are correlated with frailty 
(Krabbe et al., 2004). Another study shows that high basal IL-6 had a better predictive value 
for mortality than TNF and that both cytokines were associated with classical risk factor 
like smoking, physical inactivity and body mass index (Bruunsgaard et al., 2003). A study 
confirmed increased serum IL-6, TGF and s-ICAM in the older people but IL-6 increased 
also with poor health status (comparing SENIEUR, OCTO and NONA elderly) (Forsey et al., 
2003; Mysliwska et al., 1998). Serum IP-10 and CXCL9 levels have also been reported with 
increasing age, in contrast to IL-10 and IL-12p40. These chemokines display strong 
chemoattractant activity for Th1 lymphocytes and have been involved in the pathogenesis of 
autoimmune disorders, such as Grave’s disease or Crohn’s disease, and in metabolic 
disorders, such as diabetes mellitus or atherosclerosis (Shurin et al., 2007). A recent study 
confirms that “impaired” (poor functional status) older people express higher basal levels of 
IFN, IL-12p70, IL-6 and TNF while “unimpaired” older people express higher basal levels 
of IL-5 and IL-13 when compared to each other (Vallejo et al., 2011). 
High basal production of pro-inflammatory cytokines is generally associated with poor 
capacity to respond to TLR stimulation (Bruunsgaard et al., 1999a). Indeed, several studies 
indicate that reduced responsiveness to LPS stimulation (lower TNF, IL-1, IL-6, IL-10 and 
IL-1Ra production by whole blood cells) from 85-year olds is significantly associated with a 
worse survival and more risk factors like history of malignancies, chronic illness and 
elevated CRP levels (van den Biggelaar et al., 2004). Some whole blood studies however 
suggest that TNF and IL-6 production upon TLR stimulation is increased in aged 
individuals, in particular for SENIEUR population under 85 years. This population probably 
does not display chronic low-grade inflammation (Gabriel et al., 2002). Zinc plasma levels 
could also represent an important factor to consider (Mariani et al., 2006). 
IL-1 and TNF are the earliest mediators of the acute phase response. Both cytokines induce 
a strong wave of cytokines including IL-6 and chemokines. In the course of S. Pneumoniae 
infection, inflammatory cytokines levels tend to persist for longer periods in older patients 
in contrast to younger ones (Bruunsgaard et al., 1999b). This observation could be related to 
increased pro-inflammatory environment in aged individuals but also to reduced clearing of 
the bacteria. It should also be interpreted in the light of possible alterations of renal function 
in the older people. 
Taken together, low-grade chronic inflammation (“inflamm-aging”) seems to be a cardinal 
feature of advanced “healthy” aging. The magnitude of this process at a given age is 
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strongly influenced by multiple factors, including metabolic disorders and nutritional 
status. Indeed, poor health status and frailty will be associated with more intense 
inflammatory markers but poor responses to stimulation.  
 
 
Fig. 6. Changes in immune responses observed in aged individuals. 
4. Linking the characteristics of immune responses in the geriatric 
population to the clinical status. 
“Normal” aging is determined genetically. At the cellular level, increased lifetime is 
associated with replicative-dependent shortening of chromosomal ends, also known as 
telomeres. In immune cells, this process is linked to immunosenescence. While this 
phenomenon is the normal destiny of dividing cells, it also reflects the global history of the 
organism. Here, we will discuss how the different immune parameters of the older people 
can be linked to the clinical characteristics encountered in the geriatric population.  
4.1 Shortening of telomere length, genetic factors and hormonal changes 
Telomeres consist of simple tandem DNA repeats (10-20kb) that do not encode for any gene 
products. The main function of telomeres is to cap the chromosome ends. Telomere capping 
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is necessary to distinguish the chromosome ends from DNA breaks within the genome. 
DNA breaks within the genome lead to cell cycle arrest and DNA repair or to induction of 
apoptosis when the damage is too severe. In contrast to DNA breaks, chromosome ends do 
not provoke DNA damage responses (Ongradi & Kovesdi, 2010; Jiang et al., 2007). 
Telomeres are regarded as the molecular clock of aging, including that of the immune 
system, especially for lymphocytes. Telomere shortening is due to the end replication 
problem of DNA polymerase at each round of cell division and to diminished activity of 
telomerase that fails to add telomere repeat sequence to the end of chromosomes. 
Telomerase is active during embryogenesis but is suppressed postnataly in most somatic 
tissues. In adult humans, telomerase stays only active in germ cells, certain stem cells and 
progenitor compartment. Telomerase reactivation occurs in activated lymphocytes and 
human cancer cells (Jiang et al., 2007; Ongradi & Kovesdi, 2010). Regulation of the 
telomerase activity is complex and is limited by expression of the catalytic subunit hTERT.  
Many transcription factors act as activators (including c-Myc, SP1, USF1/2, Ets, HIF-1, 
hALP) or repressors (p53, AP1, Mad1, Wilm’s tumor 1, Smad3,...). Oestrogens activate c-myc 
thereby influencing telomerase activity. Indeed, women present longer telomeres than men. 
Cortisol inhibits telomerase activity in CD4 and CD8 T cells, suggesting a mechanism by 
which stress can negatively affect immune response (Andrews et al., 2010; 
Balasubramanyam et al., 2007). Chronic psychological stress in caregivers of Alzheimer’s 
patients or chronically ill children is associated with telomere loss in peripheral blood 
lymphocytes, possibly explained by increased cortisol levels. Another study shows reduced 
telomerase activity related to neuroendocrine and psychosocial data indicative of greater 
stress (cortisol, epinephrine, norepinephrine) in women but they failed to show an 
association between telomere shortening and negative mood or education (Andrews et al., 
2010; Jiang et al., 2007; Epel et al., 2006). In humans, telomeres shorten by 50-100 base pairs 
with each cell division. Most human tissues and organs show significant telomere 
shortening during aging, including peripheral blood mononuclear cells (PBMCs), isolated 
lymphocytes, kidney epithelium, vascular endothelial cells, hepatocytes, intestinal and lung 
epithelial cells, muscle but not for brain. Telomere length in PBMCs also correlated inversely 
with the mortality rate in 60-75 year olds. Individuals with short telomeres have a 3.18-fold 
higher mortality rates from heart diseases and 8.54-fold higher mortality rates from 
infectious diseases compared to those with relatively long telomeres but it is not a 
significant prognostic factor for survival above 85 years. In addition to telomere shortening 
with aging, accelerated shortening observed in PBMCs occurs in various human diseases 
such as myelodysplasic syndrome (Jiang et al., 2007; Andrews et al., 2010; Ohyashiki et al., 
1999), atherosclerosis and hypertension (Jiang et al., 2007; Andrews et al., 2010; Benetos et 
al., 2004), coronary artery disease, human immunodeficiency virus, rheumatoid arthritis 
(Jiang et al., 2007; Andrews et al., 2010; Steer et al., 2007) systemic lupus erythematosus, 
cognitive decline,... (Jiang et al., 2007; Andrews et al., 2010). Alzheimer patients present 
reduced telomere length in PBMCs compared to control. There was also a significant 
correlation between T cell telomere length and MMSE score, CD28 expression and an 
inverse correlation between serum TNF production and telomere shortening in T cells 
(Panossian et al., 2003). Telomere shortening is also correlated with duration of type 1 and 
type 2 diabetes and systolic blood pressure but not with diabetes complications (Astrup et 
al., 2010; Sampson et al., 2006). Another study confirms the negative correlation between 
cardiovascular risk factor or coronary heart disease and telomere length (Spyridopoulos et 
al., 2009; Brouilette et al., 2007). This study also shows that treatment with statins in patients 
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with high risk on the basis of telomere length results in substantial benefit effect (Brouilette 
et al., 2007). Oxidative stress is believed to be a major factor of accelerated aging, possible 
due to an increased pace of telomere shortening resulting from DNA damages observed 
upon smoking, obesity or cardiovascular diseases (Andrews et al., 2010; Balasubramanyam 
et al., 2007). The incidence of cancer sharply increases with aging. Telomere shortening 
appears to have a dual role in cancer formation. It was originally proposed that telomere 
shortening limits the lifespan of human cells thus acting as a tumor suppressor mechanism. 
The majority of human cancers exhibit very short telomeres, much shorter than the 
surrounding non-transformed tissue. However, more than 90% of human cancers show a 
strong reactivation of telomerase (Jiang et al., 2007). 
Early studies showed that human somatic cells have a finite number of replicative cycles. 
The term “replicative senescence” is used to describe the stage at which telomeres are 
shortened to a critical length such that a proliferative response can no longer be elicited. 
One of the approaches to prevent or delay the generation of senescent CD8+ T cells is 
based on the well-documented link between telomere shortening and overall replicative 
potential and function of T lymphocytes. Although telomerase is capable of elongating 
telomeres and is upregulated in concert with T cell activation, the activity of this enzyme 
is completely turned off in CD8+ T cells that are chronically stimulated in cell culture. 
One suggested way to improve age-dependent decline of immune function would be to 
elicit strong cellular immunity by compounds that favour telomerase activity (McElhaney 
& Effros, 2009). 
Other “genetic” factors have also been implicated in the process of immunosenescence. For 
example, IL-6 gene may be involved in the genetic regulation of longevity. IL-6 VNTR D/D 
genotypes were associated with increased levels in the blood and brain from Alzheimer’s 
disease patients and IL6 VNTR allele B could be detrimental for reaching extreme longevity 
(Capurso et al., 2007; Krabbe et al., 2004). It was also reported that -1082 IL-10 promoter 
polymorphism was increased in male centenarians as compared to younger men and this 
genotype was associated with increased production of IL-10 (Krabbe et al., 2004). 
Age is also characterized by hormone changes. It seems that oestrogens can have powerful 
immunomodulating effects, albeit mainly during stress. In vitro studies have shown that 
oestrogens deficiency leads to reduced IL-2 expression (Ku et al., 2009). Oestrogens seem to 
have important effects on B cells. A study shows that the percentage of conventional B cells 
(B-2, CD5- CD20+ cells) is significantly lower in late post menopause while B-1 cells (CD5+ 
CD20+) remain unchanged. It suggests that oestrogens may be involved in maintaining 
peripheral B-2 cell pool in women. Even if oestrogens seem to influence B cells, hormone 
replacement therapy does not influence the production of antinuclear antibodies or anti-IL-1 
antibodies observed with aging (Kamada et al., 2001). Circulating oestradiol in late 
postmenopausal women without hormonal replacement therapy is positively correlated to 
CRP and serum level of IL-6 but the association for IL-6 was not significant anymore after 
adjustement for other clinical factors. Testosterone levels were also  positively correlated 
with C-reactive protein, TNF and IL-6 even after adjustement for confounders (Maggio et 
al., 2011). 
Dehydroepiandrosterone (DHEA) has been considered for immunorestoration because 
serum levels dramatically decrease with age in both sexes. No DHEA-specific receptor has 
been identified in human T lymphocyte and it exerts probably its action indirectly via 
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downstream conversion to other steroids, in particular sex steroid. Furthermore, DHEA 
exerts also anti-glucocorticoid action. In vitro, it increases IL-2 production, NK cell activity. 
Conversely, in vivo, it decreases circulating IL-6 levels. However, no consistent in vivo data 
on immune effect of DHEA supplementation in healthy older humans has been reported. 
Conversely, it shows a beneficial effect for patients treated in the context of systemic lupus 
erythematosus (Fulop et al., 2007; Arlt & Hewison, 2004). Other studies show that DHEA 
negatively correlates with basal IL-6 seric levels in older people but this relation is more 
complex in younger people. DHEA added in culture of PBMCs inhibits IL-6 secretion 
(Straub et al., 1998; James et al., 1997). 
4.2 Comorbidities and medications 
The main confounding factor that might impact on immune functions of the geriatric patient 
is the occurrence of multiple morbidities. These pathologies have potential direct effect on 
immune cells but the influence of pharmaceutical treatments should also be kept in mind. 
Recent research has attempted to identify risk factors for mortality and functional decline in 
older persons. A 7-year community based cohort study shows that 5% of “high functioning” 
aged individuals display three or four markers of inflammation (IL-6, cholesterol, albumin, 
CRP). This was associated with a more than 6-fold increased risk of 3-year mortality and a 
more than 3-fold risk of 7-year mortality independently of other measures of health status 
(Reuben et al., 2002). This indicates that innate immune parameters are strongly linked to 
clinical status. 
4.2.1 Cardiovascular diseases and associated metabolic disorder 
Atherosclerotic plaques contain smooth muscle cells, activated T lymphocytes and 
monocyte-derived macrophages. Several epidemiological studies have linked systemic low-
grade inflammation in older populations to the prevalence and prognosis of cardiovascular 
disease. High IL-1 serum levels were associated with congestive heart failure, angina and 
dyslipidemia. High TNF serum levels have been correlated with dyslipidemia and a higher 
prevalence of cardiovascular disease in 80 year olds and with high blood pressure, insulin 
resistance and common carotid intima media thickness in healthy middle-aged men. IL-6 
acts as a marker of subclinical cardiovascular disease in older people and is a predictor of 
mortality related to cardiovascular disease (Krabbe et al., 2004). TNF directly causes 
upregulation of cellular adhesion molecules at the surface of endothelial cells and causes 
insulin resistance. IL-6 induces procoagulant changes by increasing fibrinogen, tissue factor, 
factor VIII, von Willebrand factor and platelets. Moreover, both TNF and IL-6 favour 
dyslipidemia (Bruunsgaard et al., 2003). 
TLRs are expressed throughout the body and are mainly found on professional innate 
immune cells, including macrophages, dendritic cells and mast cells but also on non-
professional immune cells such as endothelial cells and smooth muscle cells. All these cells 
are present in the atherosclerotic lesion and contribute to the inflammatory response. The 
expression of several TLRs is increased in atherosclerotic lesions. TLR4 is also increased on 
circulating monocytes from patients with coronary artery disease compared to controls.  
Several epidemiologic studies have reported elevated risk of atherosclerosis associated with 
a large number of infections (Chlamydia pneumonia, Helicobacter pylori, cytomegalovirus 
(CMV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), herpes simplex 
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virus (HSV) 1 and 2, Hepatitis virus A and B, influenza A virus). Studies have shown that 
vaccination above the age of 65 decreased the risk of acute coronary syndrome (Nichol et al., 
2003; Lundberg & Hansson, 2010). The precise mechanism whereby pathogens are able to 
accelerate atherosclerosis is unclear but TLRs are probably involved in detection and 
initiation of a subsequent inflammatory response. TLRs also recognise endogenous ligands 
that are released during necrotic cell death or are derived from the degradation of 
extracellular matrix (Heat shock protein, oxidative Low density lipoprotein, endogenous 
mRNA, fibrinogens,...). While TLR signalling pathways activate the genes encoding IL-1 
and IL-18, these mediators require a second signal resulting in cleavage of the pro-form to 
release the active molecules. This is regulated by a cytosolic protein complex (the 
“inflammasome”) that leads to caspase-1 activation (Lundberg & Hansson, 2010). Various 
molecules can activate the inflammasome: ATP, crystalline structures (explaining the role of 
inflammasome in gout and pseudogout), aluminium salts (used as adjuvants), amyloid-B 
(playing important role in Alzheimer disease), fibers (silicosis, asbestosis) or the M2 channel 
from the influenza virus. Cholesterol crystals also directly activate the inflammasome, a 
process that is implicated in the pathogenesis of atherosclerosis (Duewell et al., 2010; 
McIntire et al., 2009). It would therefore be of interest to look at inflammasome 
activation/regulation in the context of aging. Other signalling pathways, such as those 
linked to the endoplasmic reticulum (ER) stress also participate to inflammation in the 
context of metabolic disorders (Hotamisligil, 2010). Whether perturbations in ER stress 
pathways could also contribute to age-related inflammation should also be further 
investigated (Naidoo, 2009).  
Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors or statin, has 
been recognize to have beneficial effects on atherosclerosis. Statins have pleiotropic effects, 
notably on immune system and dendritic cells. It has been shown that patients treated with 
pravastatin show decreased expression of CD86 on monocyte-derived dendritic cells, a 
reduced level of IFN┙ and IL-1 after four weeks of treatment and an increase of IL-10 and 
TGF in mixed lymphocyte reactions. It also reduces plasma levels of inflammation markers  
(IL-6, TNF, CRP) and soluble CD40L without apparent link with the degree of lipid 
lowering achieved (Li et al., 2009; Schonbeck & Libby, 2004). Fenofibrate and simvastatine in 
type 2 diabetic patients with mixed dyslipidemia and in patients with hypercholesterolemia 
or impaired fasting glucose, reduce expression of TNF, IL-, IL-6 and MCP-1 by LPS-
stimulated monocytes. Both treatments significantly reduce high-sensitivity CRP levels 
(Krysiak et al., 2011b; Krysiak et al., 2011a) but there are conflicting results (Coen et al., 
2010). Statin and aspirin decrease serum levels of IL-1 and C-reactive protein in 
hypercholesterolemic patients (Ferroni et al., 2003). Valsartan in hypertension patients also 
reduces the secretion of IL-1 by LPS-stimulated PBMCs. Angiotensin II is identified as the 
main mediator of vascular complications of hypertension. It stimulates the expression of 
vascular cell adhesion molecule-1 and induces IL-1 and MCP-1 production by vascular 
smooth cells (Li et al., 2005; Ferro et al., 2000). 
Type 2 Diabetes mellitus is a serious chronic disease that is very prevalent in the developed 
world. Several studies have shown that IL-6 and IL-1 levels are independent predictors of 
type 2 diabetes development. The role of TNF is more controversial, some studies show a 
relationship between TNF and insulin resistance but this might be restricted to obese type 
2 diabetic subjects. Higher serum IL-8 levels have also been found in diabetic patients 
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(DiPenta et al., 2007). Production of IL-6, IL-8, IL-1 upon LPS stimulation could also be 
influenced by glucose concentrations and insulin levels but in vitro results on PBMCs do not 
take into account the contribution of skeletal muscles, fibroblasts and vascular endothelial 
cells (Beitland et al., 2009). 
Chronic heart failure is a major epidemiological burden in the industrialized world. 
Approximately 2% of the adult population is diagnosed with moderate or severe left 
ventricular systolic dysfunction with an incidence rate of 10 per 1000 population over the 
age of 65. Chronic inflammation interacting with increased oxidative stress, cytokine 
production, proteolytic matrix degradation and autoimmunity is implicated in heart failure 
pathophysiology by increasing cardiac injury, fibrosis and dysfunction. There are several 
sources of systemic inflammation in cardiac heart failure (TNF, IL-1, IL-6, IL-18, MCP-1) 
due to release from leukocytes and blood platelets as well as the lungs, liver, endothelium 
and the failing heart itself. These cytokines are capable of modulating cardiovascular 
performance in an autocrine, paracrine or endocrine fashion. Inflammatory cytokines may 
enhance the expression of adhesion molecules and inflammatory chemokines in endothelial 
cells which in turn may further increase the inflammatory response within the vessel wall, 
representing a pathogenic loop leading to inappropriate endothelial activation in heart 
failure. TNF superfamily ligands may directly induce endothelial cell apoptosis (Picano et 
al., 2010). Aged patients with heart failure present higher IL-6 serum levels in the acute but 
also the recovery phase of cardiac failure compare to healthy aged controls (Vo et al., 2011). 
In summary, these “metabolic disorders” are associated with chronic inflammation that 
contributes to the pathogenesis. Hence, “inflamm-aging” processes are likely to contribute 
to the development of these pathologies. Conversely, the increased prevalence of these 
diseases in the geriatric populations will affect innate immune parameters accordingly and 
favour the maintenance of low-grade inflammation.  
4.2.2 The “Frailty” syndrome 
Frailty has been defined as an age-related decline in lean body mass, decreased muscle 
strength, endurance, balance and walking performance, low activity, weight loss 
accompanied by a high risk of disability, incident falls, hospitalisation and mortality. Plasma 
levels of TNF were strongly associated with impendent death independently of dementia 
and cardiovascular disease in centenarians. It supports the hypothesis that TNF has 
specific biological effects and is a marker of the frailty syndrome in the oldest. Systemic low-
grade inflammation has been associated with decreased muscle mass as well as the 
development of functional disability in older population. TNF might directly contribute to 
sarcopenia. Indeed, in vitro experiments indicate that TNF disrupts the differentiation 
process and promotes catabolism in muscle cells. It is also responsible for increased basal 
energy expenditure, anorexia, loss of muscle and bone mass in vivo and has been associated 
with cachexia in chronic inflammatory disorders such as rheumatoid arthritis, AIDS and 
cancer. His role in septic shock is well known. The potential role of IL-6 in sarcopenia is less 
clear. Age-related sarcopenia is partly reversed by exercise. Muscle contractions induce IL-6 
production and release into the blood stream and it has been suggested that muscle-derived 
IL-6 contributes to the beneficial metabolic effect of exercise (Krabbe et al., 2004). Along the 
same line, another study shows that fatigue resistance and grip work correlate positively 
with IL-6 in older male participant. In contrast, the same group shows that older nursing 
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home residents present a worse fatigue resistance and grip work related to high levels of IL-
6, Heat shock protein 70 and TNF (Bautmans et al., 2007; Bautmans et al., 2008). High 
levels of IL-6, C-reactive protein and TNF predict an increased incidence of mobility 
limitation during a 30-month follow-up period in well functioning older people (Penninx et 
al., 2004). 
4.2.3 Neurodegenerative disorders and depression 
Cognitive impairment is an important problem with age. Epidemiological studies show an 
increasing body of evidence on the deleterious association between chronic peripheral 
cytokine elevation found in aged subjects and cognitive functions. Several studies show an 
association between serum levels of TNF, IL-1 and Alzheimer disease. In contrast, IL-6 
seems to be associated with vascular dementia (Krabbe et al., 2004; Ravaglia et al., 2007). 
Studies have suggested that inflamm-aging can be a prodrome for Alzheimer’s disease. 
Alzheimer’s disease is connected with a dysregulation in the metabolism of beta amyloid 
precursor protein with a consequent transient overproduction or a decreased degradation of 
-amyloid in the brain. IFN and other pro-inflammatory cytokines interact with processing 
and production of -amyloid peptides. Neopterin, a blood compound produced by 
monocyte-derived macrophages upon stimulation with IFN is increased in Alzheimer’s 
disease patients compared to age-matched controls. 70% of these patients are seropositive 
for cytomegalovirus and it correlates with neopterin and C-reactive protein concentrations. 
It was suggested that elevated neopterin may be a vestigial result of serum immunity to 
cytomegalovirus (Giunta et al., 2008). IL-1, IL-6 and TNF have been clearly involved in the 
local inflammatory process around amyloid plaques, might be cytotoxic when chronically 
produced and might stimulate the production of -amyloid peptides (Krabbe et al., 2004; 
Ravaglia et al., 2007). As for atherosclerosis, inflammasome activation seems to be 
implicated in Alzheimer’s disease. Amyloid  oligomers can disturb the function of K+ 
channels and decrease intracellular K+ concentration leading to activation of NALP-1 then 
caspase-1, production of IL-1 and IL-18, and cellular apoptosis through pyroptosis. Fibrillar 
amyloid  can also lead to the activation of NALP3 and lead to the same phenomenon (Cook 
et al., 2010). Plasma levels of IL-1 and TNF are higher in patients with vascular dementia 
and late onset Alzheimer’s disease when compared to control and after adjustment for 
confounding variables. IL-6 was only increased in patients with vascular dementia (Krabbe 
et al., 2004; Ravaglia et al., 2007) but not in Alzheimer’s patients (Zuliani et al., 2007). 
Alzheimer’s patients present a decrease of CD8+T lymphocytes, a slight increase of CD4+ T 
lymphocytes and CD19+ B lymphocytes compared to age-matched controls (Giunta et al., 
2008). Once again, there is a strong link between this irreversible neurodegenerative process 
and general chronic inflammation.  
Depression is also a cardinal feature of the geriatric population. Comorbidities, such as 
cardiovascular diseases, atherosclerosis, diabetes, osteoporosis, dementia, cancer or frailty 
can precipitate depressive states that are further enhanced by poor socioeconomic outcomes. 
Depression is a risk factor for low resistance to infection and insufficient response to 
vaccine. The pathogenesis and severity of depression are connected to chronic stress. 
Chronic diseases, stressfull life events, personal loss, decline in self concepts of efficacy may 
contribute to this process. Depression in older people is associated with increased exposure 
to cytomegalovirus in the past and a pro-inflammatory profile demonstrated by elevated 
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TNF, IL-6, IFN, C-reactive protein and deficiency of suppressive IL-10+cells. These 
changes negatively affect humoral and innate responses in depressed patients (Penninx et 
al., 2003; Bouhuys et al., 2004; Trzonkowski et al., 2004; Irwin & Miller, 2007). IL-6 and TNF 
have the capacity to exert direct effects on the central nervous system by stimulating the 
hypothalamic-pituitary axis activity and the release of corticotrophin-releasing factor. These 
direct effects may lead to behavioural and neurochemical changes that may induce 
depression (Penninx et al., 2003). Depression has been associated with a decreased number 
of lymphocytes and NK and altered functions, which can be modulated by antidepressant 
treatment (Bouhuys et al., 2004; Irwin & Miller, 2007). Antidepressant therapy decreases 
LPS-induced IL-1 and IL-6 in whole blood from depressed patients. IL-1 has been shown 
to up-regulate hippocampus expression of serotonin transporters and proinflammatory 
cytokines might play a causative role in the depression-related activation of hypothalamic-
pituitary-adrenal system (Himmerich et al., 2010). 
4.2.4 Osteoporosis 
Postmenopausal osteoporosis is a progressive disorder characterized by a decreased bone 
mass and increased susceptibility to fractures. It affects one out of three women after 
menopause (Breuil et al., 2010). Oestrogen deficiency leads to an uncoupling between 
activity of bone resorbing cells (osteoclasts) and bone forming cells (osteoblasts) responsible 
for accelerated bone loss. The concept of osteoimmunology recently emerged from 
increasing evidence of intimate links between bone tissue and the immune system. Indeed, 
recent studies have suggested that the increase in bone resorption induced by oestrogen 
deficiency is at least partly mediated by increased paracrine production of bone resorbing 
cytokines (Breuil et al., 2010). Multiple soluble mediators of immune cell function, including 
cytokines, chemokines and growth factors also regulate osteoblast and osteoclast activity. 
This is particularly true in pathological conditions such as rheumatoid arthritis and 
inflammatory bowel disease (Breuil et al., 2010). IL-1 is one of the most potent stimulators of 
bone resorption and IL-6 appears to be a potent osteotrophic factor that may play an 
important role in diseases characterized by increased bone resorption. Oestrogens inhibit IL-
6 gene expression (Zheng et al., 1997; De Martinis et al., 2006). TNF and IL-1 enhance bone 
resorption by stimulating development of osteoclast progenitors and increasing the activity 
of mature cells. IFN inhibits the process of IL-1 stimulated bone resorption. Some studies 
do not find any differences in the serum levels of IL-1, IL-1 and IL-6 between osteoporotic 
and normal women. In contrast, Il-1, IL-6, TNF are significantly higher in whole blood 
after polyclonal activation in osteoporotic women than controls and negative correlation is 
found between lumbar bone mineral density and IL-1, IL-6 or TNF levels (De Martinis et 
al., 2005; Zheng et al., 1997). A study performed on osteoporotic women and controls 
without oestrogen or vitamin D deficiencies shows that osteoporotic women present a 
decrease in circulating B cells, decreased basal secretion of IFN by CD4+ T lymphocytes, a 
decreased in memory CD4+ T cells expressing RANK+ and CD28+ (Breuil et al., 2010). The 
TNF-family RANK-L and its receptor RANK are key regulator and essential for the 
development and activation of osteoclasts. RANK-L is expressed in osteoblasts and can be 
upregulated by bone resorbing factors such as glucocorticoids, 1,25(OH)2D3, IL-1, IL-6, IL-
17, TNF, PGE2, parathyroid hormone. RANK-L is produced by activated T cells and can 
directly induce osteoclastogenesis.  Several factors can inhibit RANK-l such as 
osteoprotegerin, IFN, IL-12 and IL-18 (De Martinis et al., 2006). 
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Biphosphonates are currently widely used for the prevention and treatment of osteoporosis 
as well skeletal metastasis. It has been recently demonstrated that biphosphonates lead to 
the expansion and activation of T cells, these effects may represent potential novel anti-
tumor mechanisms. Another study indicates that low dose zoledronate in vitro reduces 
TNF production by monocytes, inhibits upregulation of typical maturation markers and 
NFB activation in dendritic cells (CD83, CD86, CD40) (Wolf et al., 2006). 
4.3 Chronic infections and immune “exhaustion”? 
One of the hallmarks of the “immune risk phenotype” (see table 1) in the OCTA/NONA 
subjects is the accumulation of terminally-differentiated CD8 T cells, (lacking CD27 and 
CD28) leading to inversion of the CD4:CD8 ratio. An important fraction of these cells are 
specific for cytomegalovirus (CMV) antigens. These effector memory T cells contain large 
amount of cytotoxic effector molecules like granzyme and perforin and progressively 
acquire inhibitory receptors such as KLRG1, CD57 and PD-1 (Pawelec & Derhovanessian, 
2011). Similarly, CMV-specific CD4 T cells are highly differentiated, have shorter telomeres 
and decreased telomerase induction after stimulation. These cells are thought to become 
dysfunctional and “exhausted” in old individuals (Hadrup et al., 2006). However, these cells 
are still capable of rapidly producing cytokines upon in vitro stimulation and display 
effector functions (Ouyang et al., 2003). Interestingly, a study performed on individuals 
genetically enriched for longevity, with a 30% decreased mortality risk, possess immune 
signatures different from those of the general population. Even if they are CMV-
seropositive, they fail to show the CMV-(and age-) associated alterations of immune 
parameters that CMV-seropositive general population does show (Derhovanessian et al., 
2010). As previously mentioned, it has been reported that IL-4 producing T cells with a 
CD25+ memory phenotype accumulate in a subgroup of healthy elderly people who have 
an intact humoral immune response after influenza vaccination. These apparently beneficial 
CD8+ CD25+ T cells are rare or even absent in older persons with latent CMV infection 
(Herndler-Brandstetter et al., 2005). 
Could there be a direct link between this CMV-dependent immune signature and other 
parameters of immunosenescence? Conceptually, accumulation of these memory oligoclonal 
cells with age would occupy the “immunological space” and limit homeostatic proliferation 
of naïve T cells and response to new antigens. It has also been suggested that CMV infection 
could participate to the inflamm-aging process (Trzonkowski, 2003). Whether accumulation 
of CMV-specific T cells with age is actually detrimental remains to be established (Wills, 
2011). Analysis of several recent cohorts does not support a relationship between CMV 
status, mortality or inflammatory markers (Wills 2011). Another recent study found a 
gradual increase in CMV antibody titers with deteriorating functional status in aged 
individuals (Moro-Garcia et al., 2011). CMV infection is also associated with atherosclerosis 
and the risk for heart diseases (Stranberg  TE 2009). In longitudinal studies of CMV-
seropositive patients, antibody levels have been reported to correlate inversely with survival 
in individuals with stable cardiovascular diseases, cardiovascular risk factors and in older 
women in their 70’s. Furthermore, telomere shortening of CD8 CD28- T cells correlates with 
cardiac dysfunction in CMV+ patients with coronary heart diseases (Spyridopoulos et al., 
2009).  
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In addition to these unresolved issues related to the association of CMV infection and 
disease states, the causality links are still unclear. Indeed, if CMV infection were directly 
implicated in age-dependent deterioration of immune functions and cardiovascular 
diseases, it would be highly beneficial to consider CMV eradication in the general 
population through vaccination (Pawelec, 2011). 
4.4 How living habits and nutrition status impact on immune functions 
Malnutrition is associated with a decrease in immunity and an increase in susceptibility to 
many infectious diseases, notably due to an inability to meet the energy demands associated 
with the immune response. Interventions on nutrition could have a large impact on immune 
functions (Ongradi & Kovesdi, 2010).  
It seems that caloric restriction is the only known method to prolong median as well as 
maximal lifespan in all tested animals, from invertebrates to rodents and non-human 
primates. It is able to attenuate the natural shift from naive to memory phenotype T cells 
and maintain a higher number of naive T cells in aged animals. The increase of 
proinflammatory cytokines such as IL-6, TNF and IFN can be reversed by caloric 
restriction. Caloric restriction is known to inhibit mTOR and thereby promoting autophagy 
mechanisms. It allows recycling of the cellular components to gain new building blocks for 
critical proteins by degrading momentarily unneeded proteins and even organelles (Arnold 
et al., 2011). 
The dietary intake of essential macro and micronutrients is usually inadequate in the elderly 
and several factors contribute to this deficiency: poor socioeconomic status may lead to a 
greater consumption of inexpensive foods poor in micronutrients. Nutrient deficiency is 
exacerbated by loss of appetite, lack of teeth, intestinal malabsorption and decreased energy 
requirement. Many micronutrients contribute directly or indirectly to the biological activity 
of some antioxidant enzymes, to the efficiency of immune response and to the maintenance 
of metabolic functions (Mocchegiani et al., 2011). 
Vitamin A contributes to the maintenance of epithelium integrity in the respiratory and 
gastrointestinal tracts. Pyridoxins, folic acid, vitamin E have been suggested to influence 
lymphocyte functions. Antioxidant vitamin supplements have been shown to enhance 
antibody titers upon influenza vaccination and to reduce incidence of infection over a 2-year 
study period (Lesourd, 2006). 
Lipids are also important actors in immune system. High-density lipoprotein (HDL) has 
anti-inflammatory and anti-oxidative effects and influence proximal T cell signalling. 
Conjugated linoleic acid has been shown to have anticarcinogenic, antiatherogenic and 
antidiabetic properties correlating with increased lymphocyte proliferation and decreased 
proinflammatory cytokine secretion. The most important effect is a decrease of risk and 
severity of cardiovascular diseases originating from atherosclerosis, a chronic inflammatory 
condition. Living habits can serve as anti-aging process: aerobic exercise, weight loss and 
smoking cessation can raise HDL levels and physical activity tends to lower IL-6 and C-
reactive protein serum levels (Fulop et al., 2007; Ongradi & Kovesdi, 2010). 
The potential role for vitamin D and its active metabolite 1,25(OH)2vitD in modulating the 
immune response was first appreciated 25 years ago with three important discoveries: The 
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ability of 1,25(OH)2vit D to inhibit T cell proliferation, the ability of disease-activated 
macrophages to produce 1,25 (OH)2vitD and the presence of vitamin D receptor in activated 
human inflammatory cells. 1,25(OH)2vitD suppresses proliferation and immunoglobulin 
production and delays the differentiation of B cell precursors into plasma cells. It shifts the 
balance to a Th2 cell phenotype and increased CD4/CD25 regulatory T cells. It inhibits Th17 
development and appears beneficial for autoimmunity diseases. In innate immunity, 
vitamin D enhances activation of TLRs. It promotes innate immune responses to TLR 
activation by Mycobacterium tuberculosis. 1,25(OH)2vit D increases cathelicidin, a 
antimicrobial peptide after activation of TLR1/2 but inhibits the maturation of monocyte-
derived dendritic cells (Bikle, 2009; Hewison, 2010; Schwalfenberg, 2011). By increasing 
cathelicidin, vitamin D supplementation improves the outcome of many diseases: it reduced 
dental caries and Helicobacter pylori infections. Vitamin D insufficiency is associated with 
Crohn’s disease, pour outcome in severe pneumonia and urinary tract infections 
(Schwalfenberg, 2011). Vitamin D improves physical barrier by stimulating gap junctions 
genes, adherent genes and tight junction genes (Schwalfenberg, 2011). In contrast, a study 
failed to show influence of a short-term calcium and vitamin D treatment in healthy post 
menopausal woman on IL-6, TNF and C-reactive protein serum levels (Gannage-Yared et 
al., 2003). 
Vitamin C is an essential watersoluble nutrient, which primarily exerts its effect on host 
defence mechanisms and immune homeostasis, by being the most important physiological 
antioxidant. It has been implicated as having a preventative and therapeutic role in a variety 
of diseases including scurvy, viral infections and common cold, cancer and atherosclerosis. 
A study shows that in vitro, vitamin C inhibits IL-6 and TNF production by monocytes 
after LPS stimulation and an inhibition of IL-2 production by lymphocytes after PMA 
ionomycin (Hartel et al., 2004). 
Zinc is one of the most relevant nutritional factors in aging because it affects immune 
responses, metabolic harmony and antioxidant activity. The human body contains 2-3 g zinc 
most of which is bound to proteins. Plasma pool, which is required for the distribution of 
zinc represents less than one percent of the total body content. A multitude of factors is 
likely to influence zinc intake: malnutrition, socioeconomic factors, decreased intestinal 
absorption and medications like diuretics. The recommended daily allowance for zinc in 
adult in the United States is 11mg/day for men and 8 mg/day for women. In human, the 
most prominent example of the effect of zinc deficiency on the immune system is 
acrodermatitis enteropathica, a rare autosomal recessive inheritable disease that causes 
thymic atrophy and a high susceptibility to bacterial, fungal and viral infections. It is caused 
by zinc-specific malabsorption. The intracellular concentration of free zinc is regulated by 
three mechanisms: one is transport through the plasma membrane; another involves storage 
in zincosomes and finally zinc binding to metallothionein. Metallothioneins are a group of 
low molecular weight metal binding proteins with high affinity for zinc. It distributes 
intracellular zinc and has a protective role in transient and acute stress-like conditions. 
Elevated IL-6 levels observed in aged individual are also associated with increased and 
persistent metallothioneins expression in peripheral mononuclear cells, leading to an 
increased sequestration of zinc and immune impairment. Notably, centenarians display low 
levels of metallothioneins coupled with satisfactory zinc ion availability. In vitro studies 
show that many parameters are affected by zinc: caspases, reactive oxygen species 
production, NFB and iNOS activity, superoxide dismutase, catalase, gluthatione 
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peroxidase, telomere length, several cytokines and chemokines expression. The most 
prominent effect of zinc deficiency is a decline in T cell function, the shift of a Th1 toward 
Th2 responses. Effect of zinc on cytokine levels is concentration-dependent: it stimulates 
cytokine production in monocytes in response to lipopolysaccharide with moderated 
supplementation but higher concentrations can have an antagonistic effect. With regard to 
older people, inconsistent data exist on the beneficial effect of zinc supplementation upon 
the immune efficiency due to different doses and duration of treatment. The most important 
parameter affected by physiological dose (10-25 mg/day from 1 to 3 months) is the innate 
immunity represented by the natural killer cell cytotoxicity. Zinc treatment at the dose of 
15mg a day for 1 month in older people and old infected patients restores thymic endocrine 
activity, lymphocyte mitogen proliferative response, CD4+ T cell number, peripheral 
immune efficiency and DNA repair. At clinical level, significant reduction of relapsing 
infections occurs in these patients (Mocchegiani et al., 2011; Haase & Rink, 2009; 
Mocchegiani, 2010). In hospitalized geriatric patients, poor zinc status has been associated 
with higher proportion of congestive cardiopathy, respiratory infections, gastrointestinal 
diseases and depression (Pepersack et al., 2001).  
Protein energy malnutrition is common in elderly population. It is present in 2-4% of home-
living self-sufficient older subjects and in more than 50% of institutionalized older subjects. 
During stress, the body reacts with acute phase responses associated with proinflammatory 
cytokine release from monocytes-macrophages. The cytokines induce the use of nutritional 
reserves which is particularly harmful in the older people for several reasons: 1) body 
reserves are already decreased in older individuals who exhibit osteoporosis and often 
sarcopenia 2) acute phase responses are long lasting in older people, so that more body 
reserves are used ; 3) nutritional reserves are never fully replaced in older individuals 
during recovery, since protein anabolism is decreased; 4) each acute phase response in the 
older people can therefore leads to lower nutritional reserves, mainly muscle protein 
reserves which can increase frailty (Lesourd, 2006).  
In light of these observations, it is clear that addressing the specific nutritional requirements 
in advancing age could modulate immune functions. Whey proteins are a mixture of 
globular proteins isolated from milk. It is left when milk coagulates and contains everything 
that is soluble in milk. It has been shown that older people receiving whey proteins, in 
comparison to soy proteins, present greater antibody responses against four serotypes of S. 
pneumoniae (Freeman et al., 2010). Along the same line, Enprocal, a recently formulated 
supplementary food has been designed to meet the nutritional needs of frail older people. 
The ingredients of Enprocal are dairy-based proteins (Whey protein concentrate, skim milk 
powder, whole milk powder), vitamins and minerals (calcium, zinc, vitamins C, D, B and 
A), vegetable oils and inulin. An in vitro study suggested that Enprocal displays some 
immunomodulatory properties on immune cells (Kanwar & Kanwar, 2009). Lactoferrine has 
also important immune modulator protein. It belongs to the transferrin family and bind two 
irons ions reversibly. It is synthesized by glandular epithelia and found in milk, tears, bile, 
respiratory and gastrointestinal secretions. Protein antigens and bacteria within the 
digestive systems act as stimulating agents in the process. It has pleiotropic effects: 
bactericidal, anti-fungal and anti-viral effects, anti-oxidant activity, it reduces the production 
of proinflammatory cytokines, inhibits tumour growth by inhibiting angiogenesis, 
promoting apoptosis and finally, it promotes bone growth (Pierce et al., 2009). 
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Exercise has also been shown to have influence on immunological parameter. Studies have 
found that mitogen- or influenza- induced lymphocyte proliferation was increased, the 
number of natural killer cells was greater, antibody IgM and IgG response to influenza 
vaccine two weeks post immunization was greater in active old people.  Greater levels of 
physical activity in terms of walking speed was also associated with lower serum levels of 
several inflammatory markers such as IL-6, TNF, and C-reactive protein. In contrast, 
intervention trials involving frail older people were not promising suggesting that immune 
alterations in the frail state cannot be reversed (Senchina & Kohut, 2007). A study performed 
on older men shows that older people with long-term training present reduce levels of IL-6, 
IL-1ra, IL-10, sTNFRI but an increase of MCP-1 compared to sedentary older people. It was 
associated with increases of DHEA and IGF-1 levels (Gonzalo-Calvo et al., 2011). Another 
study shows also that exercise reduces inflammatory monocytes in hypercholesterolemic 
patients (Coen et al., 2010). 
In summary, many different dietary factors are able to influence innate and adaptive 
immune parameters. It is very difficult from in vitro studies to draw hypothesis on how 
deficiency/supplementation of specific factors impact on the organism. However, clinical 
studies indicate that these factors should be taken into account and might be beneficial for 
healthy aging as a whole.  
4.5 Erosion of epithelial barriers: susceptibility to infections and potential impact on 
chronic inflammatory status 
Epithelial cells represent the first protective barrier towards invading pathogens. Aging is 
associated with alteration of these barriers, including the skin, lung, stomach, intestine and 
urinary tract. Bacteriemic pneumococcal pneumonia in persons older than 70 is associated 
with a death rate greater than 50 percent. It appears that oropharyngeal colonization with 
gram-negative bacilli plays an important predisposition role. With age, in the lung, there is a 
reduced function of the mucociliary tract, a reduced local immunity (T cells and reduced 
secreted immunoglobulin), and reduced cough reflex. All these factors but also deglutition 
trouble, reduced production of gastric acid secretion, antibiotics or antiacid treatment, 
favour the apparition of pneumonia in older people (Cretel et al., 2010; Yoshikawa, 1981).  
Older people also present more urinary infections than young people. Urinary tract 
infection has an incidence of 5-35% in men and 15-50% in women. Poor emptying of the 
urinary bladder because of reduced muscle tonicity, prostatic hypertrophy, reduced 
oestrogen and increased pH level that lead to increased bacterial adherence, previous 
genitorurinary instrumentation and perineal contamination from fecal incontinence are 
possible reasons for the high incidence (Yoshikawa, 1981; Cretel et al., 2010).   
Skin and soft tissue infection is a common complication in aged patients. Even minor 
trauma to the skin might result in serious skin and soft tissue infections because of skin 
changes (thinning of epidermis and subcutaneous tissues, decreased glandular secretions 
and atherosclerosis, pressure injuries). Skin also presents modifications of immune cells 
such as a decrease of Langerhan’s cells (Cretel et al., 2010; Desai et al., 2010; Grewe, 2001; 
Yoshikawa, 1981). 
Older patients are also at higher risk for bacterial meningitis (pneumococci, gram negative 
bacilli and listeria monocytogenes) and bacterial arthritis (Yoshikawa, 1981). 
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Gram-negative bacterial infections occur more frequently in patients older than 60 years. 
Intra-abdominal sepsis is of special importance to the older people. Complications like 
perforation, wound infection, abscess formation and pneumonia are more common in the 
older people following appendectomies. The risk of diverticulitis rapidly increases with 
aging and cholelithiasis is another disease of the aged. 
With age, the capacity of the gastrointestinal tract to protect individuals from pathogens is 
lowered because of reduced gastric pH leading to pneumonia and malabsorption, 
mechanical trouble like diverticulitis and alteration of the mucosal immune system (Cretel et 
al., 2010). The mucosal immune system consists of an integrated network of tissues, 
lymphoid and mucous membrane-associated cells and innate effectors and acquired 
molecules. The IgA isotype is key players in mucosal immunity and seems to function in 
synergy with innate immune system. Mucosal inductive sites include the Peyer’s patches; 
gut associated lymphoreticular tissues (GALT), waldeyer’s ring of tonsil and adenoid. The 
mammalian lower intestine contains up to 1012 bacteria per gram of intestine. The normal 
microbiota is essential to maintain appropriate homeostatic conditions providing energy in 
the form of short chain fatty acids and nutrients and protection against colonization by 
pathogenic bacteriae. It also plays a role in maturation of the host immune system including 
intestinal secretory soluble IgA and intraepithelial lymphocyte development. There is some 
evidence in mice that there are alterations of the mucosal immune system with age. Reduced 
levels and quality of soluble IgA and alterations of mucosal dendritic cells functions have 
been reported. Qualitative change in the composition of the microbiota has also been 
reported (fewer total anaerobes bacteroides and bifidobacterium and higher levels of 
enterobacteriacea and endotoxin-producing, gram-negative bacteria like fusobacteria, 
clostridia, eubacteria species). As a direct result of these age-related changes in the 
microbiota, the quality of the secretary IgA response can be altered, although the absolute 
amount of these antibodies is generally unchanged (Fujihashi & Kiyono, 2009). Non-
pathogenic bacteriae in the intestine play important role for protecting host from pathogens. 
It has been suggested that limited TLR stimulation will contribute to the physiological, low-
level inflammation in healthy intestine. In contrast, true pathogens induce a rapid and more 
aggressive response that is initiated by microbial danger signals and tissue damage. It is 
now known that the innate and adaptive immune activation by the microbiota prevents 
other inflammatory responses and induces cytoprotective responses of the intestine 
epithelium that are critical for intestinal homeostasis. This is achieved by low expression of 
pattern recognition receptors on intestinal epithelial cells and limited gene activation via 
NF-B. It promotes epithelial integrity through production of cytoprotective molecules such 
as heat shock proteins. Low-grade bowel inflammation is frequently present in the older 
population and may account for elevated systemic C-reactive protein and faecal 
calprotectin. Blood intestinal perfusions and oxygenation are also altered in the aged 
population. It is possible that the combination of a normally harmless bacterial signal, tissue 
injury and nutritional deficiency may trigger pathogenic inflammatory response. In the 
intestinal environment, a loss of barrier integrity may result in heightened exposure to 
exogenous components derived from the non-pathogenic intestinal microbiota and a 
breakdown in tolerance mechanisms. Impaired clearance of apoptotic cells by intestinal 
dendritic cells may lead to the accumulation of necrotic cells that release autoantigens such 
as nucleic acids, uric acid and the induction of an inflammatory dendritic cells phenotype. 
This might lead to autoimmune response and abnormal immune response to commensals. 
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Taken together, it seems that both endogenous signals (cell senescence and cumulative cell 
damage) and exogenous non-self signals (bacteria translocation through a leaky gut) may 
both contribute to chronic inflammation (Schiffrin et al., 2010). 
5. Immunosenescence and cancer 
Epidemiological studies indicate that about 55% of tumours are detected after the age of 65. 
The most frequent sites in men over 65 are represented by lung, colon, rectum, prostate and 
bladder; in women by breast, lung, colon-rectum, bladder and pancreas as well as non-
Hodgkin lymphoma. The association between age and cancer can be explained by a 
multitude of factors, including a more prolonged exposure to carcinogens in older 
individuals and an increasingly favourable milieu for the induction of neoplasm in 
senescent cells. The immune system counteracts tumour cell growth through different ways:  
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Fig. 7. External factors leading to immunosenescence. 
1) protection of the host from virus-induced tumours by eliminating or suppressing viral 
infections 2) suitable eradication of pathogens and rapid resolution of inflammation thereby 
preventing the establishment of an inflammatory environment favourable to tumorigenesis 
3) specific identification and elimination of tumour cells on the basis of their expression of 
tumour-specific antigens or molecules induced by cellular stress (a process known as 
“immunosurveillance”). Hence, reduction of T cell function and cellular immunity as seen in 
the older people could favour carcinoma development. In older people suffering from 
different types of cancer, there was a reduced number of CD3 T cells, CD4 T helper cells and 
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natural killer cells in peripheral blood compared to healthy older people (Malaguarnera et 
al., 2010; Fulop et al., 2010; Motta et al., 2003). “Inflamm-aging” processes could favour 
tumour development. For example, IL-1 plays a role in tumorigenesis (and promotes 
angiogenesis and chemoresistance). TNF plays an important role in the initiation of 
tumour by stimulation the production of nitric oxide and reactive oxygen species which can 
lead to DNA damage. Enhanced TNF levels are associated with increased risk of multiple 
myeloma, hepatocellular carcinoma, bladder, gastric and breast cancer. It also correlates 
with poor prognosis of haematological malignancies. The paracrine secretion of IL-6 acts as 
a growth factor for multiple myeloma, non-Hodgkin lymphoma, bladder, colorectal and 
renal cell carcinoma (Malaguarnera et al., 2010; Fulop et al., 2010). 
Accumulation of memory CD8 T cells might also participate to cancer development. One of 
the most intriguing evidences about the role of CD57+ T lymphocytes in cancer comes from 
the fact that metastasis-free regional lymph nodes draining different human epithelial 
tumors present a reduction in almost all immune cells, except CD57+ lymphocytes (Kanwar 
& Kanwar, 2009). CD8+CD28–CD57+ T lymphocyte clones may be the result of persistent 
stimulation by tumor-associated antigens, combined with a reduced cellular death rate 
secondary to reduced expression of the apoptosis-related molecule CD95. A long-lived 
population of CD8+CD57+CD28– perforin+ T lymphocyte clones has been reported in the 
peripheral blood of patients with multiple myeloma. Despite being more commonly found 
in patients with progressive and advanced-stage disease, this population was associated 
with superior survival. In patients with relapsed/refractory multiple myeloma treated with 
thalidomide, multivariate analysis showed that inferior survival was associated with low 
pretreatment bone marrow CD57+ cells and overall, CD8+CD57+T lymphocytes account for 
up to 25% of the marrow T cell population. Such CD8+CD57+ T lymphocytes have been 
shown to suppress T cell functions in multiple myeloma (Focosi et al., 2010).   
CD57+ lymphocytes in the lymph nodes of B-chronic lymphoid leukemia patients have 
abnormal orthogonal light-scattering signals and an abnormal density of CD57+ receptors in 
comparison with their peripheral blood CD57+lymphocytes or the CD57+ lymphocytes in 
the peripheral blood, bone marrow, and tonsils of hematological normal donors. It has been 
reported that these patients with neutropenia have higher numbers of peripheral blood 
CD8+CD57+ T lymphocytes than the non-neutropenic ones. An elevated frequency of 
CD4+CD57+ T cells was correlated with more advanced disease. The role of the 
CD4+perforin+ T cell population is at present uncertain. However, this potentially cytotoxic 
T cell population could contribute to enhancing survival of the B-chronic lymphoid 
leukemia cells through production of IL-4 and to the immunodeficient state seen frequently 
in patients with this tumor, independent of drug treatment. (Focosi et al., 2010). 
Finally, few reports analyzed the impact of immunosenescence on the complications of 
patients with cancer. Neutropenia is a complication of patients treated by chemotherapy and 
responsible of infection called febrile neutropenia. In older patients, pyrexia can be absent 
and little is known about the consequence of neutrophil defect and other immune defects on 
the increased rate of infections in old cancer patients. It is well known that CSFs enhance 
bone marrow production and is used to counteract neutropenia. CSFs have proven to be 
beneficial in old people but they still suffer from increased infection rates compared to 
younger adults. Finally, the factors influencing immunity (such as malnutrition, alteration of 
intestinal barriers, depression...) can also negatively influence the outcome of cancer in 
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geriatric patients.  So, it will be important to reconsider guidelines and management of old 
patients suffering from cancer (Crighton & Puppione, 2006). 
6. Immunosenescence and autoimmunity 
“Inflamm-aging” results in both decreased immunity to exogenous antigens and increased 
autoreactivity. It is well documented that a significant fraction of older people has low 
affinity autoantibodies in their serum and the prevalence of autoantibodies associated with 
autoimmune disease increases with age without clinical significance. Rheumatoid factors are 
present in up to 5% of young healthy individuals and increase up to five times in older 
persons such as antinuclear antibodies. A number of hypotheses have been proposed to 
explain the relationship between aging and the development of autoimmunity: reduced 
thymic output has been postulated to induce compensatory autoproliferation of T cells 
which can lead to premature T cell senescence and contribute to autoimmunity; alteration in 
apoptosis in T cells, expansion of exhausted CD4 and CD8 T cells that have lost the 
expression of CD28 are associated with autoimmune disease like rheumatoid arthritis, 
reactivation of self-reactive memory B cells, a shift from Th1 to Th2 cytokine profile that 
enhances the production of autoreactive antibodies, elevated levels of circulating 
inflammatory cytokines such as IL-6, TNF and C-reactive protein is related to age-related 
diseases such as coronary heart disease and stroke, diabetes mellitus, Alzheimer’s disease, 
lupus, Sjogren’s syndrome and rheumatoid arthritis (Grolleau-Julius et al., 2010). 
7. Immunosenescence and vaccination  
Influenza is the fifth leading cause of death in the developed world after 50 years of age. As 
such, this group is the major target of vaccination campaigns. While influenza vaccination 
has 70-90% efficacy in healthy adult in western countries, the success rate falls to 17-53% in 
older people when determined as specific immune responses. Nevertheless, vaccination 
campaigns in aged individuals result in 25% reduction of morbidity, 50% of pneumopathies, 
20% of hospital care and 70% of  mortality (Ongradi & Kovesdi, 2010; Gruver et al., 2007; 
Bouree, 2003; Nichol et al., 2003). Both humoral and cell-mediated influenza specific 
responses are lower than in young adults. Upon in vitro restimulation, peripheral blood 
mononuclear cells exhibit a decrease in the proportion of IFN+ T cells. Mortality is 
associated with coexistent bacterial infection in one third of case, which could be a 
consequence of altered innate immune responses (Ongradi & Kovesdi, 2010; Gruver et al., 
2007; Bouree, 2003). In older people, low plasma level of DHEA, decreased TNF in whole 
blood after lipopolysaccharide stimulation and increased IL-10 production in whole blood 
after PHA stimulation is correlated with lower antibody response to influenza vaccination. 
The increase of IL-10 is likely to inhibit the maturation of antigen presenting cells, together 
with decreased TNF production, hampering their migration to draining lymph node, 
compromising the subsequent induction of the specific immune response. Furthermore, IL-
10 can induce antigen-specific CD4 T cells anergy. Thus, it is intriguing that the possession 
of an anti-inflammatory genotype (high IL-10 and low TNF production) is increased 
significantly in centenarians. It is tempting to speculate that the presence of “high IL-10/low 
TNF” could be favorable in protecting against age-related diseases, particularly 
neurodegenerative diseases, but conversely it could hamper the immune response to 
infections and vaccine (Corsini et al., 2006). As said before, studies show a correlation 
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between the cytomegalovirus seropositive status and non responsiveness to influenza 
vaccine. They show that majority of volunteers fulfilling the criteria of SENIEUR protocol 
belonged to responders generating protective titers of antibodies against antigens of the 
influenza vaccine. Proinflammatory status such as elevated serum IL-6, TNF was also 
associated with non-responders. The increase of anti-inflammatory cytokines in non-
responders may be seen as a compensation for the inflammatory activity of IL-6 and TNF. 
The coexistence of high levels of IL-6 and anti-CMV IgG suggested to the authors that 
chronic infection may be one of the causes of the proinflammatory status in the non-
responding group, shrinking the capacity of immune system (Trzonkowski et al., 2003). 
Decreased TLR responsiveness of dendritic cell subsets is also associated with the inability 
to mount protective antibody responses to the trivalent inactivated influenza vaccine 
currently recommended (Panda et al., 2010). 
Infection caused by Streptococcus pneumonia account for 25-35% of bacterial pneumonia 
resulting in hospitalization, morbidities and mortality in the older people. The current 
pneumococcal polysaccharide vaccine is recommended for all individuals above 65 years of 
age and those between 18-65 years of age at risk. The data for efficacy in older people are not 
as persuasive. Antibodies levels are lower in the older people and in those with chronic 
disease, except for healthy older adults after the age of 75 (modified SENIEUR protocol) 
(Chen et al., 2009; Bouree, 2003). Antibody concentrations were found to be similar for six 
out of seven serotypes for streptococcus pneumonia after vaccination of older and young 
subjects while opsonization titers were significantly higher in six out of seven serotypes in 
the younger population. Antibody potency, as measured by the ratio of opsonization titer to 
antibody concentration was found to be significantly higher for the younger subjects for all 
serotypes. Effectiveness of antibodies seems to be reduced in the older adult population 
(Schenkein et al., 2008). Tetanus, diphtheria and pertussis vaccination coverage are low, 
persons aged of more than 60 years frequently do not have protective antibody. It is the 
same problem for hepatitis B virus vaccine (Chen et al., 2009; Bouree, 2003). 
Widely used adjuvant formulations such as those containing alum are poorly effective in 
older people compared with young subjects (Fulop et al., 2007). Alteration of TLR function 
in older adults is particularly relevant in view of the increased development and use of TLR 
agonist in vaccine. Influenza vaccine formulation in clinical trials employs the TLR5 agonist 
flagellin that would not require yearly reformulation and administration. CpG-containing 
oligonucleotides are used as TLR9-dependent vaccine adjuvants in the 7-valent 
pneumococcal conjugate vaccine and significantly enhanced the proportion of vaccine 
responders amongst HIV-infected adults. MPL, a derivative of lipid A from 
lipopolysaccharide is already used as an adjuvant in vaccines against human papillomavirus 
(Cervarix) (Shaw et al., 2011).  
8. Conclusion 
The first obvious conclusion is that immunosenescence is a complex phenomenon, which 
does not only reflect the action of time on immune cells. As discussed herein, many other 
factors, such as genetics, infection history, nutritional status, co-morbidities, socio-economic 
factors are likely to contribute to this process and its clinical impact. Geriatric medicine has 
to take into account all these specific characteristics to provide better care to this age group. 
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Data from literature and our ongoing study tend to suggest that “inflammaging” appears 
not only with age but is associated with indicators of frailty and the occurrence of 
comorbidities. Frail geriatric individuals express higher seric levels of TNF and IL-6. This 
persistent chronic inflammation could directly participate to dampened innate immune 
responses upon stimulation. Indeed, ex vivo whole blood response to molecules like LPS 
tends to be reduced in older people. In intensive care units, old people with high basal levels 
of TNF and IL-6 show increased severity of sepsis after community-acquired pneumonia 
(Mira et al., 2008). Intriguingly, increased IL-6 levels in the course of community acquired-
pneumonia, is also associated with more severe sepsis. This might reflect the fact that ex vivo 
blood experiments do not take into account cytokine production by stromal cells such as 
endothelial cells, adipocytes or muscle cells. Moreover, circulating cytokine levels are also 
influenced by kidney function that is generally altered in the course of sepsis (Gomez CMH, 
2000). Finally, it is possible that in the earlier phase of infections, old people are less efficient 
to control infection, leading to increased late inflammatory response. 
Epidemiological associations do not always reflect causality. It is possible to link altered 
immunological parameters with frailty and comorbidities (fig 3). Should we conclude that 
dampened immune responses and exacerbated inflammation contribute to the fragility of 
the organism or that specific pathologies lead to immunosenescence? It is likely that both 
hypothesis are valid and reinforce each other. It has important implications in terms of 
therapeutic interventions. Should we treat or prevent chlamydia, CMV or H. pylori that 
could be responsible for local inflammation within atherosclerotic plaques (Rosenfeld & 
Campbell, 2011)? Would treatment of metabolic disorders reduce “inflammaging” 
processes? Should we try to “rejuvenate” the immune system through cytokine or hormonal 
replacement (Dorshkind et al., 2009)? Is the CMV-associated immune phenotype responsible 
for increased mortality rate or is it possible that frail individuals undergo more frequent 
reactivation of CMV, leading to the skewing of the memory response? To answer these 
crucial questions, clear immunological and biological parameters will have to be used is 
well-defined populations to overcome the weight of confounding factors.  
Finally, to improve geriatric health, it seems clear that one should take into account several 
features of older people. We cannot imagine improving vaccinal responses without correcting 
nutritional status, frailty, controlling comorbidities and evaluate the impact of drug treatments. 
So even in this specific field, geriatric medicine requires multidisciplinary approach. 
 
Fig. 8. Potential interplays between immune function and extrinsic factors. 
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